3 not yet recruiting, 3 unknown. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 3, Unknown 3 |
| Phase 1 | 2 | Not yet recruiting 2 |
Follow Aclarubicin: new trials by email Literature Review of Aclarubicin trials Research Report on Aclarubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma Aclarubicin, Cyclophosphamide, Vincristine - Peripheral T-Cell Lymphoma (PTCL NOS), Nodal T-follicular Helper Cell Lymphoma | Phase 2 | Not yet recruiting | Shanghai Jiao Tong University School of Medicine | 36 | 2026-03-30 | 2026-04-17 |
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma Aclarubicin, Cyclophosphamide, Vincristine - Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Jiao Tong University School of Medicine | 37 | 2026-03-30 | 2026-04-17 |
| Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia Aclarubicin, Venetoclax, Azacitidine - Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Jiao Tong University School of Medicine | 112 | 2026-03-15 | 2026-03-20 |
| Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML Cladribine Injection, Aclarubicin, G-CSF - Acute Myeloid Leukemia, Elderly Patients | Phase 2 | Unknown | Sun Yat-sen University | 34 | 2021-03-01 | 2020-12-17 |
| Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients AraC, Aclarubicin, Peg-G-CSF - Acute Myeloid Leukemia | Phase 2 | Unknown | Shandong University | 120 | 2017-01-01 | 2017-02-07 |
| Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia Cladribine, G-CSF, Aclarubicin - Acute Myeloid Leukemia, Relapse Leukemia | Phase 2 | Unknown | Sun Yat-sen University | 48 | 2016-01-01 | 2019-08-20 |
Leukemia, Myeloid, Acute (4) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphoma, T-Cell, Peripheral (1) · Recurrence (1) · Sezary Syndrome (1)
Shanghai Jiao Tong University School of Medicine (3) · Sun Yat-sen University (2) · Shandong University (1)
China (6)
Junmin Li, Professor (2) · Junmin Li (1) · Liang Wang, M.D. (1)